Reciprocal Allosteric Modulation of Carbon Monoxide and Warfarin Binding to Ferrous Human Serum Heme-Albumin

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bocedi, Alessio ^a   De Sanctis, Giampiero ^b   Ciaccio, Chiara ^a   Tundo, Grazia R ^a,c   Di Masi, Alessandra ^d   Fanali, Gabriella ^e   Nicoletti, Francesco P ^f   Fasano, Mauro ^e   Smulevich, Giulietta ^f   Ascenzi, Paolo ^d   Coletta, Massimo ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems   (Italy)

^d ROMA TRE UNIVERSITY   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; FERROUS ION; HUMAN SERUM ALBUMIN; WARFARIN;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; CONTROLLED STUDY; LIGAND BINDING; QUANTITATIVE ANALYSIS; RAMAN SPECTROMETRY; STRUCTURE ANALYSIS; THERMODYNAMICS;

ALLOSTERIC REGULATION; CARBON MONOXIDE; FERROUS COMPOUNDS; HEME; HUMANS; KINETICS; PROTEIN BINDING; SERUM ALBUMIN; THERMODYNAMICS; WARFARIN;

EID: 84875284224     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058842     Document Type: Article

References (70)

1. Peters T Jr (1996) All about Albumin: Biochemistry, Genetics and Medical Applications. Academic Press, San Diego and London.
2. Minchiotti L, Galliano M, Kragh-Hansen U, Peters T Jr, (2008) Mutations and polymorphisms of the gene of the major human blood protein, serum albumin. Hum Mutat 29: 1007-1016.
3. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, et al (2012) Human serum albumin: from bench to bedside. Mol Aspects Med 33: 209-290.
4. He X, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358: 209-215.
5. Carter DC, Ho JX (1994) Structure of serum albumin. Adv Protein Chem 45: 153-203.
6. Curry S, Mandelkov H, Brick P, Franks N (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 5: 827-835.
7. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng 12: 439-446.
8. Bhattacharya AA, Curry S, Franks NP (2000) Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem 275: 38731-38738.
9. Bhattacharya AA, Grüne T, Curry S (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 303: 721-732.
10. Petitpas I, Bhattacharya AA, Twine S, East M, Curry S (2001) Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J Biol Chem 276: 22804-22809.
11. Curry S (2002) Beyond expansion: structural studies on the transport roles of human serum albumin, Vox Sang. 83(Suppl. 1): 315-319.
12. Wardell M, Wang Z, Ho JX, Robert J, Rüker F, et al (2002) The atomic structure of human methemalbumin at 1.9 Å. Biochem Biophys Res Commun 291: 813-819.
13. Petitpas I, Petersen CE, Ha CE, Bhattacharya AA, Zunszain PA, et al (2003) Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia. Proc Natl Acad Sci USA 100: 6440-6445.
14. Zunszain PA, Ghuman J, Komatsu T, Tsuchida E, Curry S (2003) Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct Biol 3: 6.
15. Sakurai Y, Ma SF, Watanabe H, Yamaotsu N, Hirono S, et al (2004) Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates. Pharm Res 21: 285-292.
16. Fasano M, Curry S, Terreno E, Galliano M, Fanali G, et al (2005) The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57: 787-796.
17. Ascenzi P, Bocedi A, Notari S, Fanali G, Fesce R, et al (2006) Allosteric modulation of drug binding to human serum albumin. Mini Rev Med Chem 6: 483-489.
18. Zunszain PA, Ghuman J, McDonagh AF, Curry S (2008) Crystallographic analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXalpha. J Mol Biol 381: 394-406.
19. Simard JR, Zunszain PA, Hamilton JA, Curry S (2006) Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. J Mol Biol 361: 336-351.
20. Bocedi A, Notari S, Menegatti E, Fanali G, Fasano M, et al (2005) Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin. FEBS J 272: 6287-6296.
21. Fasano M, Fanali G, Leboffe L, Ascenzi P (2007) Heme binding to albuminoid proteins is the result of recent evolution. IUBMB Life 59: 436-440.
22. Fasano M, Baroni S, Vannini A, Ascenzi P, Aime S (2001) Relaxometric characterization of human hemalbumin. J Biol Inorg Chem 6: 650-658.
23. Nicoletti FP, Howes BD, Fittipaldi M, Fanali G, Fasano M, et al (2008) Ibuprofen induces an allosteric conformational transition in the heme complex of human serum albumin with significant effects on heme ligation. J Am Chem Soc 130: 11677-11688.
24. Sudlow G, Birkett DJ, Wade DN (1975) The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11: 824-832.
25. Sudlow G, Birkett DJ, Wade DN (1976) Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12: 1052-1061.
26. Diana FJ, Veronich K, Kapoor AL (1989) Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin. J Pharm Sci 78: 195-199.
27. Yamasaki K, Maruyama T, Yoshimoto K, Tsutsumi Y, Narazaki R, et al (1999) Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. Biochim Biophys Acta 1432: 313-323.
28. Baroni S, Mattu M, Vannini A, Cipollone R, Aime S, et al (2001) Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin: a spectroscopic study. Eur J Biochem 268: 6214-6220.
29. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, et al (2005) Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 353: 38-52.
30. Chuang VTG, Otagiri M (2002) How do fatty acids cause allosteric binding of drugs to human serum albumin? Pharm Res 19: 1458-1464.
31. Fanali G, Fesce R, Agrati C, Ascenzi P, Fasano M (2005) Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin: optical and NMR spectroscopy characterization. FEBS J 272: 4672-4683.
32. Kragh-Hansen U, Watanabe H, Nakajou K, Iwao Y, Otagiri M (2006) Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. J Mol Biol 363: 702-712.
33. Fanali G, Bocedi A, Ascenzi P, Fasano M (2007) Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. An optical and NMR spectroscopic study. FEBS J 274: 4491-4502.
34. Fasano M, Fanali G, Fesce R, Ascenzi P (2008) Human serum haem-albumin: an allosteric 'chronosteric' protein. In: Bolognesi M, di Prisco G, Verde C (eds) Dioxygen binding and sensing proteins. Springer, Heidelberg, pp. 121-131.
35. Fanali G, Pariani G, Ascenzi P, Fasano M (2009) Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin- An optical and NMR spectroscopic investigation. FEBS J 276: 2241-2250.
36. Wilting J, van der Giesen WF, Janssen LH, Weideman MM, Otagiri M, et al (1980) The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis. J Biol Chem 255: 3032-3037.
37. Janssen LH, Van Wilgenburg MT, Wilting J (1981) Human serum albumin as an allosteric two-state protein: evidence from effects of calcium and warfarin on proton binding behaviour. Biochim Biophys Acta 669: 244-250.
38. Dockal M, Chang M, Carter DC, Rüker F (2000) Five recombinant fragments of human serum albumin. Tools for the characterization of the warfarin binding site. Protein Sci 9: 1455-1465.
39. Monzani E, Bonafé B, Fallarini A, Redaelli C, Casella L, et al (2001) Enzymatic properties of hemalbumin. Biochim Biophys Acta 1547: 302-312.
40. Ascenzi P, Bocedi A, Bolli A, Fasano M, Notari S, et al (2005) Allosteric modulation of monomeric proteins. Biochem Mol Biol Educ 33: 169-176.
41. Komatsu T, Ohmichi N, Nakagawa A, Zunszain PA, Curry S, et al (2005) O2 and CO binding properties of artificial hemoproteins formed by complexing iron protoporphyrin IX with human serum albumin mutants. J Am Chem Soc 127: 15933-15942.
42. Ascenzi P, Fasano M (2007) Abacavir modulates peroxynitrite-mediated oxidation of ferrous nitrosylated human serum heme-albumin. Biochem Biophys Res Commun 353: 469-474.
43. Ascenzi P, Imperi F, Coletta M, Fasano M (2008) Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin. Biochem Biophys Res Commun 369: 686-691.
44. Ascenzi P, di Masi A, De Sanctis G, Coletta M, Fasano M (2009) Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites. Biochem Biophys Res Commun 387: 83-86.
45. Cao Y, Nicoletti FP, De Sanctis G, Bocedi A, Ciaccio C, et al (2012) Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding. J Biol Inorg Chem 17: 133-147.
46. Chen RF (1967) Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem 242: 173-181.
47. Sogami M, Foster JF (1968) Isomerization reactions of charcoal-defatted bovine plasma albumin. The N-F transition and acid expansion. Biochemistry 7: 2172-2182.
48. Cabrera-Crespo J, Goncalves VM, Martins EA, Grellet S, Lopes AP, et al (2000) Albumin purification from human placenta. Biotechnol Appl Biochem 31: 101-106.
49. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
50. Boffi A, Das TK, Della Longa S, Spagnuolo C, Rousseau DL (1999) Pentacoordinate hemin derivatives in sodium dodecyl sulfate micelles: model systems for the assignment of the fifth ligand in ferric heme proteins. Biophys J 77: 1143-1149.
51. Kamal JK, Behere DV (2002) Spectroscopic studies on human serum albumin and methemalbumin: optical, steady-state, and picosecond time-resolved fluorescence studies, and kinetics of substrate oxidation by methemalbumin. J Biol Inorg Chem 7: 273-283.
52. Antonini E, Brunori M (1971) Hemoglobin and Myoglobin in their Reactions with Ligands, North Holland Publishing Co., Amsterdam and London.
53. Coletta M, Angeletti M, De Sanctis G, Cerroni L, Giardina B, et al (1996) Kinetic evidence for the existence of a rate-limiting step in the reaction of ferric hemoproteins with anionic ligands. Eur J Biochem 235: 49-53.
54. Ascenzi P, Fasano M (2009) Serum heme-albumin: an allosteric protein. IUBMB Life 61: 1118-1122.
55. Ascenzi P, Fasano M (2010) Allostery in a monomeric protein: the case of human serum albumin. Biophys Chem 148: 16-22.
56. Spiro TG, Wasbotten IH (2005) CO as a vibrational probe of heme protein active sites. J Inorg Biochem 99: 34-44.
57. Ray GB, Li XY, Ibers JA, Sessler JL, Spiro TG (1994) How far can proteins bend the FeCO unit? Distal polar and steric effects in heme proteins and models. J Am Chem Soc 116: 162-176.
58. Vogel KM, Kozlowski PM, Zgierski MZ, Spiro TG (2000) Role of the axial ligand in hemeνCO backbonding; DFT analysis of vibrational data. Inorg Chim Acta 297: 11-17.
59. Fitos I, Visy J, Simonyi M, Hermansson J (1999) Stereoselective allosteric binding interaction on human serum albumin between ibuprofen and lorazepam acetate. Chirality 11: 115-120.
60. Bertucci C, Domenici E (2002) Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem 9: 1463-1481.
61. Fitos I, Visy J, Kardos J (2002) Stereoselective kinetics of warfarin binding to human serum albumin: effect of an allosteric interaction. Chirality 14: 442-448.
62. Kragh-Hansen U, Chuang VT, Otagiri M (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 25, 695-704.
63. Ascenzi P, Bocedi A, Notari S, Menegatti E, Fasano M (2005) Heme impairs allosterically drug binding to human serum albumin Sudlow's site I. Biochem Biophys Res Commun 334: 481-486.
64. Ahmad E, Rabbani G, Zaidi N, Singh S, Rehan M, et al (2011) Stereo-selectivity of human serum albumin to enantiomeric and isoelectronic pollutants dissected by spectroscopy, calorimetry and bioinformatics. PLoS One 6: e26186.
65. Ahmad E, Rabbani G, Zaidi N, Ahmad B, Khan RH (2012) Pollutant-induced modulation in conformation and β-lactamase activity of human serum albumin. PLoS One 7: e38372.
66. Gullotta F, di Masi A, Ascenzi P (2012) Carbon monoxide: an unusual drug. IUBMB Life 64: 378-386.
67. Gullotta F, di Masi A, Coletta M, Ascenzi P (2012) CO metabolism, sensing, and signaling. Biofactors 38: 1-13.
68. Adam SS, McDuffie JR, Ortel TL, Willing JW Jr (2012) Comparative effectiveness of Warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism. A systematic review. Ann Intern Med, in the press.
69. Coletta M, Ascenzi P, Traylor TG, Brunori M (1985) Kinetics of carbon monoxide binding to monomeric hemoproteins. Role of the proximal histidine. J Biol Chem 260: 4151-4155.
70. Ciaccio C, Coletta A, De Sanctis G, Marini S, Coletta M (2008) Cooperativity and allostery in haemoglobin function. IUBMB life 60: 112-123.